期刊文献+

孕中期产妇出生缺陷筛查的临床研究

Clinical study on birth defects screening of mid-pregnancy parturients
下载PDF
导出
摘要 目的了解486例孕中期产妇3种主要出生缺陷(神经管畸形、21-三体、18-三体)的检出情况。方法采用罗氏全自动发光免疫分析仪,对486例孕中期产妇进行甲胎蛋白(AFP)、绒毛膜促性腺激素(HCG)、游离雌三醇(uE3)的检测。结果所检测孕中期产妇中,21-三体高危儿6例,神经管畸形3例,18-三体0例。占出生缺陷筛查总人数的阳性率为1.85%;其中,年龄35岁及以上孕中期产妇,21-三体高危儿4例,神经管畸形2例,占总筛查人数的阳性率为1.23%,占总阳性率的66.7%。结论孕中期产妇患出生缺陷的风险率较高,对其进行出生缺陷指标的筛查,临床价值较大。 Objective To understand the detection status of three main birth defects,neural tube malformation,trisomy 21 and trisomy 18,in 486 mid-pregnancy parturients. Methods The Roche fully automatic immunofluorescent analyzer was adopted to detect AFP, HCG and uE3 in 486 mid-pregnancy parturients. Results Among detected mid-pregnancy parturients,trisomy 21 was in 6 cases,neural tube malformation was in 3 cases and trisomy 18 was zero. The positive rate of birth defects accounted for 1.85%of total screening parturients number. Among mid-pregnancy parturients aged ≥35 years old,high risk trisomy 21 was in 4 cases and neural tube malformation was in 2 eases,which accounted for 1.23 % of total screening mid-pregnancy period and 66.7% of total positive rate. Conclusion Mid-pregnancy parturients have the high risk of birth defects. Conducting the birth defects index screening on them has the larger clinical value. mid pregnancy period; birth defects; screening;
作者 王名燕 曹洋
出处 《检验医学与临床》 CAS 2012年第11期1297-1297,1299,共2页 Laboratory Medicine and Clinic
关键词 孕中期 出生缺陷 筛查 mid-pregnancy period birth defects screening
  • 相关文献

参考文献6

二级参考文献10

  • 1许锬,王滨有,施霖,陈飞.孕妇外周血中胎儿mRNA的定量分析[J].中国实用妇科与产科杂志,2005,21(1):38-40. 被引量:1
  • 2Abdul-Hamid S, Fox R, Martin I. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy. J Obstet Gynaecol, 2004, 24:374 - 376.
  • 3Rahim RR, Cuckle HS, Sehmi IK, et al. Compromise ultrasound dating policy in maternal serum screening for Down syndrome.Prenat Diagn, 2002, 2:1181 - 1184.
  • 4Jou HJ, Wu SC, Lu YM, et al. Weight-correction formula for materhal serum screening for Down syndrome in Taiwan. J Formos Med Assoc, 2000, 99:931 - 935.
  • 5Watt He, Wald NJ. Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrom and neural tube defects. Prenat Diagn, 1998, 18:842 - 845.
  • 6Souter VL, Nyberg DA, Benn PA, et al. Correlation of seeond-trimester sonography and Biochemical Markers. Obstet Gynecol Surv. 2004, 59 :758 - 760.
  • 7Wald NJ, George L, Smith D, et al. Serum screening for Down' s syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynecol,1996,103:407.
  • 8Rudnicka AR, Wald N J, Hutfly W, et al. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn, 2002, 22 : 893 - 897.
  • 9Huttly W, Rudnicka A, Wald NJ. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Prenat Diagn, 2004, 24 : 804 - 807.
  • 10Tuangsit Wataganara,Erik S. LeShane,Antonio Farina,Geralyn M. Messerlian,Thomas Lee,Jacob A. Canick,Diana W. Bianchi. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18[J] 2003,Human Genetics(2):204~208

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部